[1][2] NITD was founded in 2002 as a public-private partnership between Swiss-based pharmaceutical company Novartis and the Singapore Economic Development Board.
[1] NITD states its goals are "to discover novel treatments and prevention methods for major tropical diseases."
Their website states they hope to have at least two drug candidates going through clinical trials in patients by the year 2012.
[3] In 2017, NITD moved out of Singapore to be beside Novartis' infectious diseases research headquarters in Emeryville, California, United States.
[6] NITD also supports training opportunities for post-graduate students and post-doctoral fellows.